免疫药物基因组学的意义和挑战
Lara Hanci Handzha1,2, Yusuke Nakamura1
1National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka, Japan.
Frontiers in immunology
|December 24, 2025
概括
免疫药物基因组学结合了遗传学和免疫系统分析,以预测药物反应和改善治疗方法. 这种方法通过了解药物安全性和疗效的个体差异来增强个性化医疗.
科学领域:
- 免疫学 免疫学 免疫学
- 药物基因组学 药物基因组学
- 遗传学 是一个遗传学.
背景情况:
- 药物基因组学传统上将遗传变异与药物反应联系在一起.
- 人们越来越认识到免疫系统对药物的有效性和安全性至关重要.
- 药物反应的个体间变异性需要先进的预测模型.
研究的目的:
- 审查基因和免疫因素在预测药物反应中的整合.
- 探索HLA多态性和免疫谱系动态如何影响治疗结果.
- 突出免疫药物基因组学在推进精准医学中的作用.
主要方法:
- 综合遗传数据 (HLA多态) 和免疫谱系分析 (TCR,BCR) 的当前文献的审查.
- 对动态克隆转移和多样性的免疫谱系测序的分析.
- 在各种临床环境中检查耐受性机制.
主要成果:
- HLA多样性和免疫谱系异质性显著影响药物反应和毒性.
- 免疫谱系测序提供了机制性见解和疾病和治疗的预测生物标志物.
- 遗传和免疫数据的整合为个性化预测和更安全的药物设计提供了一个框架.
结论:
- 免疫药物基因组学对于理解药物反应的个体间差异至关重要.
- 这个领域通过个性化的预测和精确的免疫疗法来推进个性化医疗.
- 未来的方向包括整合遗传和免疫谱系分析,以加强治疗策略.
相关概念视频
Microorganisms in Medicine and Therapeutics
911
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
911
Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
Dosage Regimen: Individualization
151
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
151
Drug Products: Biologics, Biosimilars and Interchangeables
214
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
214
Analysis of Population Pharmacokinetic Data
648
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
648
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


